Document:

Exhibit 10.3

 

FINAL FORM

 

[FORM OF] TRANSACTION SUPPORT AGREEMENT

 

This TRANSACTION SUPPORT
AGREEMENT (this “Agreement”) is entered into as of May 1, 2021, by and among Montes Archimedes Acquisition Corp.,
a Delaware corporation (“MAAC”), Roivant Sciences Ltd., a Bermuda exempted limited company (the “Company”),
and [●], a [●] ([collectively,] the “Shareholder”).
Each of MAAC, the Company and the Shareholder are sometimes referred to herein individually as a “Party” and collectively
as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them
in the Business Combination Agreement (as defined below).

 

RECITALS

 

WHEREAS, concurrently
with the execution of this Agreement, MAAC, the Company and Rhine Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary
of the Company (“Merger Sub”), entered into that certain Business Combination Agreement (as amended, supplemented or
otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement”);

 

WHEREAS, the Business
Combination Agreement contemplates that, on the terms and subject to the conditions therein, (a) on the Closing Date prior to the Closing,
the Company will consummate the Company Pre-Closing Steps, and (b) on the Closing Date promptly following consummation of the Company
Pre-Closing Steps, Merger Sub will merge with and into MAAC, with MAAC as the surviving corporation in the merger and, after giving effect
to such merger, becoming a wholly-owned Subsidiary of the Company;

 

WHEREAS, the Shareholder
is, as of the date hereof, the record and beneficial owner of the number and class or series (as applicable) of the Company Pre-Closing
Common Shares set forth on Schedule A hereto (together with any other Company Pre-Closing Common Shares that the Shareholder acquires
record or beneficial ownership of after the date hereof and prior to the Effective Time, collectively, the “Subject Company Shares”);

 

WHEREAS, in consideration
for the benefits to be received by the Shareholder under the terms of the Business Combination Agreement and as a material inducement
to the Company and MAAC agreeing to enter into and consummate the transactions contemplated by the Business Combination Agreement, the
Shareholder agrees to enter into this Agreement and to be bound by the agreements, covenants and obligations contained in this Agreement;
and

 

WHEREAS, the Parties
acknowledge and agree that the Company and MAAC would not have entered into and agreed to consummate the transactions contemplated by
the Business Combination Agreement without the Shareholder entering into this Agreement and agreeing to be bound by the agreements, covenants
and obligations contained in this Agreement.

 

NOW, THEREFORE, in
consideration of the premises and the mutual promises set forth herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

 

     

     

    

 

AGREEMENT

 

1.                  
Company Shareholder Consent and Related Matters. Prior to the earlier of (A) the termination
of this Agreement in accordance with its terms and (B) the Effective Time, (i) to the extent that it is necessary or reasonably
advisable, in each case, as mutually reasonably determined and agreed by MAAC and the Company (such determination and agreement not to
be unreasonably withheld, conditioned or delayed by either MAAC or the Company, as applicable) for matters, actions or proposals to be
approved by the Shareholder in connection with, or otherwise in furtherance of, the transactions contemplated by the Business Combination
Agreement and/or the Ancillary Documents, if any, the Shareholder shall vote (or cause to be voted) the Subject Company Shares in favor
of and/or consent to any such matters, actions or proposals promptly following written request thereof from MAAC and the Company, as
applicable (provided, however, that the Shareholder shall not be required to vote for, or consent to, any action that would
result in any adverse economic or other material changes to the form of the Business Combination Agreement and/or the Ancillary Documents
as approved by the Board of Directors of the Company on or prior to the date hereof (any such action, an “Adverse Action”)),
and (ii) the Shareholder shall vote (or cause to be voted) the Subject Company Shares against and withhold consent with respect to (A)
any Company Acquisition Proposal or (B) any other matter, action or proposal that would reasonably be expected to result in (x) a breach
of any of the Company’s covenants, agreements or obligations under the Business Combination Agreement or (y) any of the conditions
to the Closing set forth in Article VI of the Business Combination Agreement not being satisfied.

 

2.                  
Other Covenants and Agreements.

 

(a)               
The Shareholder and the Company hereby agrees that, notwithstanding anything to the contrary in any such agreement, (i) each of
the agreements set forth on Schedule B hereto shall be automatically terminated and of no further force and effect (including any
provisions of any such agreement that, by its terms, survive such termination, effective as of, and subject to and conditioned upon the
occurrence of, the Closing and (ii) upon such termination neither the Company nor any of its Affiliates (including the other Group Companies
and, from and after the Effective Time, MAAC and its Affiliates) shall have any further Liabilities under each such agreement.

 

(b)               
The Shareholder acknowledges and agrees that the Shareholder is, and during the term of this Agreement shall continue to be, bound
by the confidentiality obligations set forth in the Sixth Amended and Restated Shareholders Agreement, dated June 17, 2020, by and among
the Company and the Company Shareholders party thereto (the “Shareholders Agreement”).

 

    2 

     

    

 

(c)                The
Shareholder shall not, and the Shareholder shall cause its controlled Affiliates and its and their respective officers and directors
not to, and shall use reasonable best efforts to cause its other Representatives not to, at or at any time prior to the Effective
Time, issue any press releases or make any public announcements with respect to this Agreement, the Business Combination Agreement
or the transactions contemplated hereby or thereby that contain any information that is not, at the applicable time, already
publicly available (other than as a result of disclosure by the Shareholder in violation of any applicable confidentiality
obligations) without the prior written consent of the Company and MAAC; provided, however, that the Shareholder and
its Representatives may issue or make, as applicable, any such press release, public announcement or other communication if such
press release, public announcement or other communication is required by applicable Law or applicable rule of a stock exchange on
which its or any of its Affiliates’ securities are listed, in which case the Shareholder or its applicable Representatives
shall, to the extent reasonably practicable and unless and to the extent prohibited by such applicable Law, reasonably consult with
the Company and MAAC in connection therewith and provide the Company and MAAC with an opportunity to review and comment on such
press release, public announcement or communication and shall consider any such comments in good faith. Notwithstanding anything to
the contrary in this Section 2(c) or otherwise in this Agreement, the Shareholder and its Representatives may provide general
information about the subject matter of this Agreement, the Business Combination Agreement and the transactions contemplated hereby
and thereby (1) to their respective affiliates, their and their affiliates’ respective directors, officers, employees,
partners, members, agents, attorneys, consultants and financial and other advisors, and potential sources of capital (including
potential limited partners), (2) to the extent required by any federal, state, national, foreign or other regulatory or
self-regulatory authority having jurisdiction over the Shareholder or its Representatives, (3) to any Person if necessary to effect
compliance with any law, rule, regulation, investigation, audit, request or order of a Governmental Entity of competent jurisdiction
that is applicable to the Shareholder or its Representatives, including in response to any subpoena or other legal process, audit or
examinations or (4) to any direct or indirect former, current or prospective investor or in connection with normal fund raising or
related marketing or informational or reporting activities (so long as, in the case of this clause (4), the recipients of such
information are subject to customary confidentiality obligations prior to the receipt of such information); provided further
that in the case of the foregoing clause (1), the recipients of such information are subject to policies to protect such
confidential information or agree to hold confidential the information in a manner substantially consistent with the terms of the
confidentiality provisions of the Shareholders Agreement and that, in the case of the foregoing clauses (2) and (3), the Shareholder
or its Representatives promptly notifies the Company of such disclosure to the extent the Shareholder or its Representatives are
legally permitted to give such notice and it is reasonably practicable; provided further that no such notice shall be
required where disclosure is made (x) in response to and required by a general request by a regulatory or self-regulatory authority
of competent jurisdiction or (y) in connection with and required by a routine audit or examination by a bank examiner or auditor and
such audit or examination does not reference the Company, this Agreement or the Business Combination Agreement.

 

(d)               
The Shareholder (i) shall be bound by and subject to Section 8.18 (Trust Account Waiver) of the Business Combination Agreement
to the same extent as such provisions apply to the Company, as if the Shareholder is directly party thereto, and (ii) shall vote its Company
Pre-Closing Common Shares, exercise its director appointment and termination rights, execute any documents and otherwise use its reasonable
best efforts to take, or cause to be taken, all actions, in each case, as may be necessary or appropriate so that, immediately after the
Effective Time, the Company Board consists of the number of directors, and is comprised of the individuals, determined pursuant to Section
5.16(a) (Post-Closing Directors) of the Business Combination Agreement.

 

(e)               
[Except with respect to the transactions contemplated by the PIPE Subscription Agreement entered into by and among the Shareholder,
the Company and MAAC on the date hereof (the “Shareholder PIPE Subscription”),]2
if applicable, the Shareholder hereby agrees to promptly execute and deliver all additional agreements, documents or instruments, take,
or cause to be taken, all actions and provide, or cause to be provided, all additional information or other materials as may be necessary
or reasonably advisable, in each case, as mutually reasonably determined and agreed to by MAAC and the Company (such determination and
agreement not to be unreasonably withheld, conditioned or delayed by either MAAC or the Company), in connection with, or otherwise in
furtherance of, the transactions and the other covenants and agreements contemplated by the Business Combination Agreement or this Agreement
(provided, however, that in no event shall the Shareholder be obligated to take, approve or consent to an Adverse Action).
Notwithstanding the foregoing, the Shareholder shall not be required to provide any information which is, based on the advice of outside
counsel, subject to legal privilege.

 

 

2 Note to Draft: To be included
for Company shareholders that are also PIPE investors

 

    3 

     

    

 

(f)                 [The
Shareholder hereby acknowledges and agrees that, in connection with the consummation of the Company Pre-Closing Steps on the Closing
Date, all of the Non-Voting Common Shares held by the Shareholder as of immediately prior to such consummation of the Company
Pre-Closing Steps will be converted on a one for one basis into voting Company Pre-Closing Common Shares (the “Share
Conversion”), subject to the prior expiration or termination of the applicable waiting period under the HSR Act with
respect to such Share Conversion. Without limiting Section 2(e), the Shareholder shall use reasonable best efforts to take
any actions reasonably necessary or appropriate to cause the Share Conversion to be consummated, including by (A) making any
appropriate filings pursuant to the HSR Act with respect to the Share Conversion as promptly as reasonably practicable (and in any
event within ten (10) Business Days) following the date of this Agreement, (B) obtaining any other approvals of any Governmental
Entity as may be required in connection with the Share Conversion and (C) responding as promptly as reasonably practicable to any
requests by any Governmental Entity for additional information and documentary material that may be requested pursuant to the HSR
Act or in connection with such other required approvals of any Governmental Entity. Without limiting the foregoing, the Shareholder
and its applicable Affiliates shall not extend any waiting period, review period or comparable period under the HSR Act or in
connection with such other required approvals of any Governmental Entity or enter into any agreement with any Governmental Entity
not to consummate the Share Conversion except with the prior written consent of the Company and MAAC. The Shareholder shall promptly
inform the Company and MAAC of any communication received by the Shareholder from any Governmental Entity regarding the Share
Conversion. The Shareholder shall give the Company and its counsel, and MAAC and its counsel, a reasonable opportunity to review in
advance, and consider in good faith the views thereof in connection with, any proposed written communication to any Governmental
Entity relating to the Share Conversion. The Shareholder agrees not to participate in any substantive meeting or discussion, either
in person or by telephone with any Governmental Entity in connection with the Share Conversion unless it consults with the Company
and MAAC in advance and, to the extent not prohibited by such Governmental Entity, gives the Company and MAAC the opportunity to
attend and participate in such meeting or discussion.]3

 

(g)                [Without
limiting Section 2(e), the Shareholder shall use reasonable best efforts to consummate the Shareholder PIPE Subscription, including
by (A) making any appropriate filings pursuant to the HSR Act with respect to the Shareholder PIPE Subscription as promptly as
reasonably practicable (and in any event within ten (10) Business Days) following the date of this Agreement, (B) obtaining any
other approvals of any Governmental Entity as may be required in connection with the Shareholder PIPE Subscription and (C)
responding as promptly as reasonably practicable to any requests by any Governmental Entity for additional information and
documentary material that may be requested pursuant to the HSR Act or in connection with such other required approvals of any
Governmental Entity. Without limiting the foregoing, the Shareholder and its applicable Affiliates shall not extend any waiting
period, review period or comparable period under the HSR Act or in connection with such other required approvals of any Governmental
Entity except with the prior written consent of the Company and MAAC. Notwithstanding anything to the contrary contained herein, it
is expressly understood and agreed that: (i) the Shareholder shall have no obligation to litigate or contest any Proceeding in
respect of such filings and approvals and (ii) the Shareholder shall be under no obligation to proffer, make proposals, negotiate,
execute, carry out or submit to agreements or Orders providing for (A) the sale, transfer, license, divestiture, encumbrance or
other disposition or holding separate (through the establishment of a trust or otherwise) of any assets, categories of assets,
operations or categories of operations of the Shareholder or any of its Affiliates, (B) the discontinuation of any product or
service of the Shareholder or any of its Affiliates, or (C) the imposition of any limitation or regulation on the ability of the
Shareholder or any of its Affiliates to freely conduct their business or own their respective assets. The Shareholder shall promptly
inform the Company and MAAC of any communication received by the Shareholder from any Governmental Entity regarding the Shareholder
PIPE Subscription. The Shareholder shall give the Company and its counsel, and MAAC and its counsel, a reasonable opportunity to
review in advance, and consider in good faith the views thereof in connection with, any proposed written communication to any
Governmental Entity relating to the Shareholder PIPE Subscription. The Shareholder agrees not to participate in any substantive
meeting or discussion, either in person or by telephone with any Governmental Entity in connection with the Shareholder PIPE
Subscription unless it consults with the Company and MAAC in advance and, to the extent not prohibited by such Governmental Entity,
gives the Company and MAAC the opportunity to attend and participate in such meeting or discussion. For the avoidance of doubt, it
is hereby acknowledged and agreed that nothing in this Agreement shall limit the conditions set forth in Section 3(a) and
3(c) of the PIPE Subscription Agreement entered into in connection with the Shareholder PIPE Subscription.]4

 

 

3 Note to Draft: To be included
for the Founder.

 

4 Note to Draft: To be included
for Shareholders whose participation in the PIPE Financing requires an HSR filing or other governmental approvals.

 

    4 

     

    

 

(h)               
[The Shareholder agrees not to participate in any Piggyback Registration (as defined in the Registration Rights Agreement) pursuant
to Section 2 of the Registration Rights Agreement during the Holdback Period (as defined in the Registration Rights Agreement).]5

 

(i)                
The Shareholder acknowledges and agrees that MAAC and the Company are entering into the Business Combination Agreement in reliance
upon the Shareholder entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the
agreements, covenants and obligations contained in this Agreement and, but for the Shareholder entering into this Agreement and agreeing
to be bound by, and perform, or otherwise comply with, as applicable, the agreements, covenants and obligations contained in this Agreement,
MAAC and the Company would not have entered into or agreed to consummate the transactions contemplated by the Business Combination Agreement.

 

3.                  
Shareholder Representations and Warranties. The Shareholder represents and warrants to MAAC
as follows:

 

(a)               
If the Shareholder is not an individual, the Shareholder is a corporation, limited liability company or other applicable business
entity duly organized or formed, as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each
case, with respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction
of formation or organization (as applicable).

 

(b)               
The Shareholder (if not an individual) has the requisite corporate, limited liability company or other similar power and authority
and, if the Shareholder is an individual, legal capacity to execute and deliver this Agreement, to perform his, her or its covenants,
agreements and obligations hereunder (including, for the avoidance of doubt, those covenants, agreements and obligations hereunder that
relate to the provisions of the Business Combination Agreement), and to consummate the transactions contemplated hereby. The execution
and delivery of this Agreement has been duly authorized by all necessary corporate or other action on the part of the Shareholder. This
Agreement has been duly and validly executed and delivered by the Shareholder and constitutes a valid, legal and binding agreement of
the Shareholder (assuming that this Agreement is duly authorized, executed and delivered by MAAC and the Company), enforceable against
the Shareholder in accordance with its terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium or other Laws affecting
generally the enforcement of creditors’ rights and subject to general principles of equity).

 

(c)                No
consent, approval or authorization of, or designation, declaration or filing with, any Governmental Entity is required on the part
of the Shareholder with respect to the Shareholder’s execution, delivery or performance of his, her or its covenants,
agreements or obligations under this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations
under this Agreement that relate to the provisions of the Business Combination Agreement) or the consummation of the transactions
contemplated hereby, except for any consents, approvals, authorizations, designations, declarations, waivers or filings, the absence
of which would not reasonably be expected to adversely affect the ability of the Shareholder to perform, or otherwise comply with,
any of his, her or its covenants, agreements or obligations hereunder in any material respect. 

 

 

5 Note to Draft: To be included
for the Founder and Matthew Gline

 

    5 

     

    

 

(d)               
Subject to the due execution and delivery of the Company Shareholder Written Consent and that certain Large Lot Shareholders’
Consent and Waiver and Founder’s Waiver relating to the transactions contemplated by the Business Combination Agreement on or prior
to the date hereof, none of the execution or delivery of this Agreement by the Shareholder, the performance by the Shareholder of any
of his, her or its covenants, agreements or obligations under this Agreement (including, for the avoidance of doubt, those covenants,
agreements and obligations under this Agreement that relate to the provisions of the Business Combination Agreement) or the consummation
of the transactions contemplated hereby will, directly or indirectly (with or without due notice or lapse of time or both) (i) if the
Shareholder is not an individual, result in any breach of any provision of the Shareholder’s Governing Documents, (ii) result in
a violation or breach of, or constitute a default or give rise to any right of termination, Consent, cancellation, amendment, modification,
suspension, revocation or acceleration under, any of the terms, conditions or provisions of any Contract to which the Shareholder is a
party, (iii) violate, or constitute a breach under, any Order or applicable Law to which the Shareholder or any of his, her or its properties
or assets are bound or (iv) result in the creation of any Lien upon the Subject Company Shares (other than as expressly provided under
this Agreement), except, in the case of any of clauses (ii) and (iii) above, as would not reasonably be expected to
adversely affect the ability of the Shareholder to perform, or otherwise comply with, any of his, her or its covenants, agreements or
obligations hereunder in any material respect.

 

(e)               
The Shareholder is, as of the date hereof, the record and beneficial owner of the Company Pre-Closing Common Shares set forth on
Schedule A hereto. The Shareholder has the sole right to vote (and provide consent in respect of, as applicable) the Subject Company
Shares and, except for this Agreement, the Business Combination Agreement and the Company Shareholders Agreement, the Shareholder is not
party to or bound by (i) any option, warrant, purchase right or other Contract that would reasonably be expected (either alone or in connection
with one or more events, developments or events (including the satisfaction or waiver of any conditions precedent)) to require the Shareholder
to Transfer any of the Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer
of any of the Subject Company Shares (other than the Company Shareholders Agreement and the other Governing Documents of the Company)
that would reasonably be expected to adversely affect the ability of the Shareholder to perform, or otherwise comply with, any of his,
her or its covenants, agreements or obligations hereunder in any material respect.

 

(f)                
There is no Proceeding pending or, to the Shareholder’s knowledge, threatened against or involving the Shareholder or any
of his, her or its Affiliates that, if adversely decided or resolved, would reasonably be expected to adversely affect the ability of
the Shareholder to perform, or otherwise comply with, any of its covenants, agreements or obligations under this Agreement in any material
respect.

 

(g)               
The Shareholder, on his, her or its own behalf and on behalf of his, her or its Representatives, acknowledges, represents, warrants
and agrees that he, she or it has conducted his, her or its own independent review and analysis of, and, based thereon, has formed an
independent judgment concerning, the business, assets, condition, operations and prospects of, MAAC and the transactions contemplated
by this Agreement, the Business Combination Agreement and the other applicable Ancillary Documents to which he, she or it is or will be
a party as he, she or it and his, her or its Representatives have deemed necessary to enable him, her or it to make an informed decision
with respect to the execution, delivery and performance of this Agreement or the other Ancillary Documents to which he, she or it is or
will be a party and the transactions contemplated hereby and thereby.

 

    6 

     

    

 

(h)                In
entering into this Agreement and the other Ancillary Documents to which he, she or it is or will be a party, the Shareholder has
relied solely on his, her or its own investigation and analysis and the representations and warranties expressly set forth in the
Ancillary Documents to which he, she or it is or will be a party (including the PIPE Subscription
Agreement entered into by and among the Shareholder, the Company and MAAC on the date hereof, if applicable) and no other
representations or warranties of MAAC, the Company or any other Person, either express or implied, and the Shareholder, on his, her
or its own behalf and on behalf of his, her or its Representatives, acknowledges, represents, warrants and agrees that, except for
the representations and warranties expressly set forth in this Agreement or in the other Ancillary Documents to which he, she or it
is or will be a party (including the PIPE Subscription Agreement entered into by and among the Shareholder, the Company and MAAC on
the date hereof, if applicable), none of MAAC, the Company or any other Person makes or has made any representation or warranty,
either express or implied, to the Shareholder in connection with or related to this Agreement, the Business Combination Agreement or
the other Ancillary Documents or the transactions contemplated hereby or thereby.

 

4.                  
Company and MAAC Acknowledgement. In entering into this Agreement, the Business Combination
Agreement and the other Ancillary Documents to it is or will be a party, each of the Company and MAAC have not relied on any representations
or warranties of the Shareholder, either express or implied, except for the representations and warranties of the Shareholder expressly
set forth in this Agreement or in the other Ancillary Documents to which he, she or it is or will be a party (including the PIPE Subscription
Agreement entered into by and among the Shareholder, the Company and MAAC on the date hereof, if applicable).

 

5.                  
Transfer of Subject Securities. From and after the date hereof and until the earlier of (A)
the termination of this Agreement in accordance with its terms and (B) the Effective Time, the Shareholder agrees not to (a) Transfer
any of the Subject Company Shares, (b) enter into (i) any option, warrant, purchase right, or other Contract that would reasonably be
expected (either alone or in connection with one or more events, developments or events (including the satisfaction or waiver of any conditions
precedent)) to require the Shareholder to Transfer the Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect
to the voting or Transfer of the Subject Company Shares, or (c) take any actions in furtherance of any of the matters described in the
foregoing clauses (a) or (b), unless, in the case of clauses (a) through (c), the Shareholder causes any transferee of any
such Transfer to enter into a written agreement in form and substance reasonably satisfactory to MAAC and the Company agreeing to be bound
by this Agreement (which will include, for the avoidance of doubt, all of the covenants, agreements and obligations of the Shareholder
hereunder and the making of all the representations and warranties of the Shareholder set forth in Section 3 with respect to such
transferee and his, her or its Subject Company Shares received upon such Transfer, as applicable) prior and as a condition to the occurrence
of such Transfer; provided that, if the Shareholder
is not an individual, a Transfer of securities in the Shareholder by an equityholder of the Shareholder shall not require the transferee
to enter into such written agreement so long as (x) following such Transfer, the Shareholder continues to hold the Subject Company Shares
and to have the exclusive right to vote and to take all other actions related to the ownership of the Subject Company Shares without restriction
and (y) such Transfer would otherwise be permitted under the Shareholders Agreement. For purposes of this Agreement, “Transfer”
means any direct or indirect sale, transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest in or
disposition or encumbrance of an interest (whether with or without consideration, whether voluntarily or involuntarily or by operation
of law or otherwise). 

 

    7 

     

    

 

6.                   Termination.
This Agreement shall automatically terminate, without any notice or other action by any Party, and be void ab initio upon the
earlier of (a) the Effective Time and (b) the termination of the Business Combination Agreement in accordance with its terms. Upon
termination of this Agreement as provided in the immediately preceding sentence, none of the Parties shall have any further
obligations or Liabilities under, or with respect to, this Agreement. Notwithstanding the foregoing or anything to the contrary in
this Agreement, (i) the termination of this Agreement pursuant to clause (b) of this Section 6 shall not affect any
Liability on the part of any Party for a Willful Breach of any covenant or agreement set forth in this Agreement prior to such
termination or Fraud, (ii) Section 2(b), Section 2(c) and the representations and warranties set forth in Sections
3(g) and (h) shall each survive any termination of this Agreement, (iii) Section 2(d) (solely to the extent that
it relates to Section 8.18 (Trust Account Waiver) of the Business Combination Agreement) shall survive any termination of
this Agreement pursuant to Section 6(b) and (iv) this Section 6 and Sections 8, 9, 10, 11, 12, 13, 14
and 15 shall survive any termination of this Agreement. For purposes of this Section 6, (x) “Willful
Breach” means a material breach of this Agreement that is a consequence of an act or a failure to act by the breaching
Party with the knowledge that the taking of such act or such failure to act would, or would reasonably be expected to, constitute or
result in a breach of this Agreement and (y) “Fraud” means an act or omission by a Party, and requires: (A) a
false or incorrect representation or warranty expressly set made by such Party in this Agreement, (B) with actual knowledge (as
opposed to constructive, imputed or implied knowledge) by the Party making such representation or warranty that such representation
or warranty expressly set forth in this Agreement is false or incorrect, (C) an intention to deceive another Party, to induce him,
her or it to enter into this Agreement, (D) another Party, in justifiable or reasonable reliance upon such false or incorrect
representation or warranty expressly set forth in this Agreement, causing such Party entering into this Agreement, and (E) another
Party suffering damage by reason of such reliance. For the avoidance of doubt, “Fraud” does not include any claim for
equitable fraud, promissory fraud, unfair dealings fraud or any torts (including a claim for fraud or alleged fraud) based on
negligence or recklessness.

 

7.                  
Fiduciary Duties. Notwithstanding anything in this Agreement to the contrary, (a) the Shareholder
makes no agreement or understanding herein in any capacity other than in such Shareholder’s capacity as a record holder and beneficial
owner of the Subject Company Shares and, (i.e., if such Shareholder is an individual, not in such Shareholder’s capacity as a director,
officer or employee of any Group Company or in such Shareholder’s capacity as a trustee or fiduciary of any Company Equity Plan,
as applicable), and (b) nothing herein will be construed to limit or affect any action or inaction by such Shareholder if such Shareholder
is an individual, or, if such Shareholder is not an individual, any representative of such Shareholder serving as a member of the board
of directors of any Group Company or as an officer, employee or fiduciary of any Group Company or any Company Equity Plan, in each case,
acting in such person’s capacity as a director, officer, employee or fiduciary of such Group Company or any Company Equity Plan.

 

8.                  
Notices. All notices, requests, claims, demands and other communications hereunder shall be
in writing and shall be given (and shall be deemed to have been duly given) by delivery in person, by e-mail (having obtained electronic
delivery confirmation thereof (i.e., an electronic record of the sender that the email was sent to the intended recipient thereof without
an “error” or similar message that such email was not received by such intended recipient)), or by registered or certified
mail (postage prepaid, return receipt requested) (upon receipt thereof) to the other Parties as follows:

 

If to MAAC, to:

 

c/o Patient Square Capital

724 Oak Grove, Suite 130

Menlo Park, California 94025

	 	Attention: 	Maria Walker
	 	Email: 	maria@patientsquarecapital.com

 

with a copy (which shall not constitute notice)
to:

 

Kirkland & Ellis LLP

601 Lexington Avenue

New York, NY 10022

	 	Attention: 	Michael Weisser, P.C.; Ryan Brissette
	 	Email: 	michael.weisser@kirkland.com; ryan.brissette@kirkland.com

 

    8 

     

    

 

If to the Company, to:

 

Roivant Sciences Ltd.

Suite 1, 3rd Floor,

11-12 St. James’s Square,

London SW1Y 4LB,

United Kingdom

	 	Attention: 	Matthew Gline
	 	E-mail: 	matthew.gline@roivant.com

legalnotices@roivant.com

 

with a copy (which shall not constitute notice)
to:

 

Davis Polk & Wardwell LLP

450 Lexington Avenue

New York, NY 10017

	 	Attention: 	Derek Dostal; Lee Hochbaum; Brian Wolfe

		Email:	derek.dostal@davispolk.com; lee.hochbaum@davispolk.com;

 brian.wolfe@davispolk.com

 

If to the Shareholder, to the address on
the Shareholder’s signature page hereto or to an address of such Shareholder in the books and records of the Company;

 

or to such other address as the Party to whom notice is given may have
previously furnished to the others in writing in the manner set forth above.

 

9.                  
Entire Agreement. This Agreement, the Business Combination Agreement and documents referred
to herein and therein (including the Ancillary Documents) constitute the entire agreement of the Parties with respect to the subject matter
of this Agreement, and supersede all prior agreements and undertakings, both written and oral, among the Parties with respect to the subject
matter of this Agreement, except as otherwise expressly provided in this Agreement.

 

10.              
Amendments and Waivers; Assignment. Any provision of this Agreement may be amended or waived
if, and only if, such amendment or waiver is in writing and signed by the Shareholder, the Company and MAAC. Notwithstanding the foregoing,
no failure or delay by any Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise of any other right hereunder. Neither this Agreement nor any of the rights, interests or
obligations hereunder shall be assignable by the Shareholder or the Company without MAAC’s prior written consent (to be withheld
or given in its sole discretion) or by MAAC without the Company’s prior written consent (to be withheld or given in its sole discretion).
Any attempted assignment of this Agreement not in accordance with the terms of this Section 10 shall be null and void ab initio.

 

11.              
Fees and Expenses. Except, in the case of MAAC and the Company, as otherwise expressly set
forth in the Business Combination Agreement, all fees and expenses incurred in connection with this Agreement and the transactions contemplated
hereby, including the fees and disbursements of counsel, financial advisors and accountants, shall be paid by the Party incurring such
fees or expenses. 

 

12.              
No Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties
and their respective successors and permitted assigns and is not intended, nor shall be construed, to give any Person, other than the
Parties and their respective successors and permitted assigns, any legal or equitable right, benefit or remedy of any nature whatsoever
by reason this Agreement. Nothing in this Agreement, expressed or implied, is intended to, or shall be deemed to, create a joint venture.

 

    9 

     

    

 

13.              
 Miscellaneous. Sections 8.5 (Governing Law), 8.7 (Construction; Interpretation),
8.10 (Severability), 8.11 (Counterparts; Electronic Signatures), 8.15 (Waiver of Jury Trial), 8.16 (Submission
to Jurisdiction) and 8.17 (Remedies) of the Business Combination Agreement are incorporated herein by reference and shall apply
to this Agreement, mutatis mutandis.

 

14.              
No Ownership Interest. Nothing contained in this Agreement will be deemed to vest in MAAC
or any MAAC Non-Party Affiliate any direct or indirect ownership or incidents of ownership of or with respect to the Subject Company Shares.
All rights, ownership and economic benefits of and relating to the Subject Company Shares shall remain vested in and belong to the Shareholder,
and MAAC (and each MAAC Non-Party Affiliate) shall have no authority to manage, direct, superintend, restrict, regulate, govern or administer
any of the policies or operations of Company or exercise any power or authority to direct Shareholder in the voting of any of the Subject
Company Shares, except as otherwise expressly provided herein with respect to the Subject Company Shares. Except as otherwise set forth
in Section 1, the Shareholder shall not be restricted from voting in favor of, against or abstaining with respect to any other
matters presented to the stockholders of the Company. Without limiting the foregoing, nothing in this Agreement shall obligate or require
the Shareholder to exercise an option to purchase any Company Shares.

 

[Signature page follows]

 

    10 

     

    

 

IN WITNESS WHEREOF, the Parties
have executed and delivered this Transaction Support Agreement as of the date first above written.

 

	 	MONTES ARCHIMEDES ACQUISITION CORP.

 

	 	By:	 

	 	Name:

	 	Title:

 

	 	ROIVANT SCIENCES LTD.

 

	 	By:	 

	 	Name:

	 	Title:

 

[Signature Page to Transaction Support Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the Parties
have executed and delivered this Transaction Support Agreement as of the date first above written.

 

	 	[SHAREHOLDER(S)]

 

	 	By:	 

	 	Name:

	 	Title:

 

[Signature Page to Transaction Support Agreement]

 

     

     

    

 

SCHEDULE A6

 

	Class/Series of Securities	Number of Shares
	Company Pre-Closing 

Common Shares	[●]

 

 

6 Note to Draft: Company to complete for each Company Shareholder.

 

     

     

    

 

SCHEDULE B

 

The Company Shareholders Agreements.Exhibit 10.4

 

FINAL FORM

 

[FORM OF] LOCK-UP AGREEMENT

 

This LOCK-UP AGREEMENT
(this “Agreement”) is entered into as of May 1, 2021, by and among Roivant Sciences Ltd., a Bermuda exempted limited
company (the “Company”), and the undersigned person[s] ([collectively,] the “Holder”). Each of the
Company and the Holder are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Business Combination Agreement
(as defined below).

 

RECITALS

 

WHEREAS, concurrently
with the execution of this Agreement, the Company, Montes Archimedes Acquisition Corp., a Delaware corporation (“MAAC”),
and Rhine Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”),
are entering into that certain Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time
in accordance with its terms, the “Business Combination Agreement”);

 

WHEREAS, the Business
Combination Agreement contemplates that, on the terms and subject to the conditions therein, (a) on the Closing Date prior to the Closing,
the Company will consummate the Company Pre-Closing Steps and (b) on the Closing Date promptly following consummation of the Company Pre-Closing
Steps, Merger Sub will merge with and into MAAC, with MAAC as the surviving corporation in the merger and, after giving effect to such
merger, becoming a wholly-owned Subsidiary of the Company;

 

WHEREAS, the Holder
is, as of the date hereof, a holder of Company Pre-Closing Common Shares, MAAC Warrants and/or Company Equity Awards, as applicable;

 

WHEREAS, in connection
with the consummation of the transactions contemplated by the Business Combination Agreement, the Holder will be, as of immediately following
the Effective Time, a holder of Company Post-Closing Common Shares, Company Warrants, Adjusted Options, Adjusted RSU Awards and/or Adjusted
CVAR Awards, as applicable;

 

[WHEREAS, concurrently with the execution
of this Agreement, the Company, the Holder and certain other Persons are entering into that certain Sponsor Support Agreement (as it may
be amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Sponsor Support Agreement”);]1

 

WHEREAS, in consideration
for the benefits to be received by the Holder under the terms of the Business Combination Agreement and as a material inducement to the
Company and MAAC agreeing to enter into and consummate the transactions contemplated by the Business Combination Agreement, the Holder
agrees to enter into this Agreement and to be bound by the agreements, covenants and obligations contained in this Agreement; and

 

WHEREAS, the
Parties acknowledge and agree that the Company would not have entered into and agreed to consummate the transactions contemplated by
the Business Combination Agreement without the Holder entering into this Agreement and agreeing to be bound by the agreements,
covenants and obligations contained in this Agreement.

 

 

		1	To be included for the MAAC Sponsor.

 

     

     

    

 

NOW, THEREFORE, in
consideration of the premises and the mutual promises set forth herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

 

AGREEMENT

 

1.              Lock-Up Provisions.

 

(a)           [For
the applicable Lock-Up Period (as defined below), notwithstanding anything to the contrary set forth in the Company’s bye-laws
or any other agreement, except as set forth herein, the Holder shall not (i) lend, offer, pledge, sell, contract to sell, sell any option
or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer
or dispose of, directly or indirectly, (a) any Company Post-Closing Common Shares that are outstanding and owned by the Holder immediately
following the Effective Time (the “Covered Common Shares”) or (b) any securities that are outstanding and owned
by the Holder immediately following the Effective Time that are convertible into or exercisable or exchangeable (directly or indirectly)
for Company Post-Closing Common Shares (including, without limitation, Company Post-Closing Common Shares or other securities that may
be issued after the Effective Time upon exercise, vesting or settlement, as applicable, of any stock option, restricted stock unit, capped
value appreciation right or other equity or equity-based award or interest, including for the avoidance of doubt, Adjusted Options, Adjusted
RSU Awards and Adjusted CVAR Awards (the securities described in this clause (b), the “Covered Other Securities” and,
together with the Covered Common Shares, the “Covered Securities”)), or (ii) enter into any swap, hedge or other arrangement
that transfers to another, in whole or in part, any of the economic consequences of ownership of any Covered Securities, whether any
such transaction described in clause (i) or (ii) above is to be settled by delivery of Covered Securities, in cash or otherwise, and
whether any such transaction is made or executed by or on behalf of someone other than the Holder (each, a “Sale Transaction”),
in each case, without the prior written consent of the Company. The foregoing limitations shall remain in full force and effect for a
period of (A) with respect to 100% of the Covered Securities, six (6) months from and after the Closing Date, (B) with respect to 75%
of the Covered Securities (rounded up to the nearest whole share or other security, as the case may be), twelve (12) months from and
after the Closing Date and (C) with respect to 50% of the Covered Securities (rounded up to the nearest whole share or other security,
as the case may be), thirty-six (36) months from and after the Closing Date (the periods set forth in the foregoing clauses (A) through
(C), as applicable, the “Lock-Up Period”), with the percentages set forth in this sentence applying to the aggregate
holdings of Covered Securities held by all entities constituting the Holder, and calculated on an aggregated basis. The Company may impose
stop-transfer instructions with respect to the Covered Securities subject to the restrictions set forth in this Section 1(a). For the
avoidance of doubt, the Covered Securities shall be measured on an as-exercised or as-converted basis, as applicable.]2

 

 

		2	To be included for Holders other than the MAAC Sponsor.

 

    2

     

    

 

(a)            [For
the applicable Lock-Up Period (as defined below), notwithstanding anything to the contrary set forth in the Company’s bye-laws or
any other agreement, except as set forth herein, the Holder shall not (i) lend, offer, pledge, sell, contract to sell, sell any option
or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer
or dispose of, directly or indirectly, any Company Post-Closing Common Shares or Company Warrants (it being understood and agreed that,
for purposes of this Agreement, references to “Company Warrants” shall be deemed to include Company Post-Closing Common Shares
underlying such Company Warrants), as applicable, that are outstanding and owned by the Holder immediately following the Effective Time
(the “Covered Securities”) or (ii) enter into any swap, hedge or other arrangement that transfers to another, in whole
or in part, any of the economic consequences of ownership of any Covered Securities, whether any such transaction described in clause
(i) or (ii) above is to be settled by delivery of Covered Securities, in cash or otherwise, and whether any such transaction is made or
executed by or on behalf of someone other than the Holder (each, a “Sale Transaction”), in each case, without the prior
written consent of the Company. The foregoing limitations shall remain in full force and effect for a period of: (A) with respect to 100%
of the Company Post-Closing Common Shares owned by the Holder as of immediately following the Effective Time, six (6) months from and
after the Closing Date, (B) with respect to 25% of the Company Post-Closing Common Shares owned by the Holder as of immediately following
the Effective Time, the earlier of (I) twelve (12) months following the date on which the applicable Earn-Out Shares (as such term is
defined in the Sponsor Support Agreement) vest pursuant to Section 2 of the Sponsor Support Agreement and (II) seventy-two (72) months
from and after the Closing Date, (C) with respect to 50% of the Company Post-Closing Common Shares owned by the Holder as of immediately
following the Effective Time, thirty-six (36) months from and after the Closing Date, (D) with respect to 100% of the Company Warrants
owned by the Holder as of immediately following the Effective Time, six (6) months from and after the Closing Date, (E) with respect to
75% of the Company Warrants owned by the Holder as of immediately following the Effective Time, twelve (12) months from and after the
Closing Date and (F) with respect to 50% of the Company Warrants owned by the Holder as of immediately following the Effective Time, thirty-six
(36) months from and after the Closing Date (the periods set forth in the foregoing clauses (A) through (F), as applicable, the “Lock-Up
Period”). Notwithstanding the foregoing, the Lock-Up Period described in clauses (A), (B) and/or (C) shall apply to Covered
Securities that are Company Post-Closing Common Shares (other than the Earn-out Shares), the $15 Earn-Out Shares (as such term is defined
in the Sponsor Support Agreement) and the $20 Earn-out Shares (as such term is defined in the Sponsor Support Agreement) in the manner
(and in the applicable proportions) set forth on Annex A hereto. The Company may impose stop-transfer instructions with respect
to the Covered Securities subject to the restrictions set forth in this Section 1(a). For the avoidance of doubt, (1) any Earn-Out Shares
that vest pursuant to the Sponsor Support Agreement shall remain subject to any applicable Lock-Up Period set forth herein and (2) notwithstanding
the expiration of any Lock-Up Period with respect to any Earn-Out Shares, such shares shall remain subject to any applicable restrictions
set forth in the Sponsor Support Agreement. For the avoidance of doubt, the Covered Securities shall be measured on an as-exercised or
as-converted basis, as applicable.]3

 

 

		3	To be included for the MAAC Sponsor.

 

    3

     

    

 

(b)           The restrictions set forth in Section 1(a) shall not apply to:

 

(i)            any securities issued to the Holder in connection with a PIPE Subscription Agreement, including any Covered Securities received
in exchange for, or converted for, securities acquired pursuant to a PIPE Subscription Agreement;

 

(ii)           [if the Holder is a party to the Registration Rights Agreement, the sale of any Company Post-Closing Common Shares pursuant to
the Holder’s exercise of the piggyback registration rights set forth in, and in accordance with the terms and conditions of, the
Registration Rights Agreement, so long as such sale is consummated during the six (6) months from and after the Closing Date;]4

 

(iii)          a
transfer of any or all of the Covered Securities:

 

(A)        by gift, will, intestate succession or charitable contribution;

 

(B)         to any Permitted Transferee (as defined below);

 

(C)         by
operation of law or pursuant to a court order or an order of a regulatory agency, such as a qualified domestic relations order, divorce
decree or separation agreement;

 

(D)        to
the Company pursuant to the exercise, in each case on a “cashless” or “net exercise” basis, of any [Covered Other
Securities]5 [Company Warrants]6
(provided that any Company Post-Closing Common Shares received by the Holder upon any such exercise will be subject to the
terms of Section 1(a));

 

(E)         [for
purposes of satisfying any withholding taxes and/or estimated taxes due as a result of the exercise, vesting or settlement, as applicable,
of any Covered Other Securities;]7

 

(F)          in
connection with the Company’s consummation of a liquidation, merger, amalgamation, share exchange, reorganization, tender offer
or other similar transaction that results in all of the Company’s shareholders having the right to exchange their equity holdings
in the Company for cash, securities or other property; or

 

(G)         by
pledging, hypothecating or otherwise granting a security interest in Covered Securities in a bona fide transaction to one or more unaffiliated
lending institutions as collateral or security for any margin loan and any transfer in the event of foreclosure upon such Covered
Securities as a result of a default on such margin loan (so long as any such pledge, hypothecation or grant of security interest shall
be on terms consistent with customary margin loans, and the Holder shall provide the Company with written notice prior to entering into
such margin loan);

 

 

		4	To be included for Holders other than the Founder, Matthew Gline
and the MAAC Sponsor.

 

		5	To be included for Holders other than the MAAC Sponsor.

 

		6	To be included for the MAAC Sponsor.

 

		7	To be included for Holders other than the MAAC Sponsor.

 

    4

     

    

 

(H)         a sale or other transfer by an Upstream Equity Holder of its direct or indirect common stock or membership, partnership
or other equity ownership interest in the Holder (whether or not for consideration);

 

(I)           [to cover any direct or indirect tax obligations (including satisfying any withholding taxes and/or estimated taxes due
as a result of the exercise, vesting or settlement, as applicable, of any securities) that may accrue to the Holder, the Holder’s
direct or indirect owners or the Holder’s Permitted Transferees (so long as, in all such transfers pursuant to this clause (I),
no more than 5% in the aggregate of the Holder’s Covered Securities are transferred);]8

 

provided, however,
that in the case of any of the foregoing clauses (A), (B) or (C), the transferee in such transfer shall agree in a writing delivered to
the Company that the Covered Securities so transferred will thereafter continue be subject to the terms of Section 1(a) unless released
earlier in accordance with Section 1(h) of this Agreement; and

 

(iv)          the
establishment or modification of a written plan meeting the requirements of Rule 10b5-1 of the Exchange Act that does not provide for
the sale or transfer of Covered Securities during the Lock-Up Period; provided that, to the extent a public announcement or filing
under the Exchange Act is required regarding the establishment or modification of such plan, such announcement or filing shall include
a statement to the effect that no sales or transfers of Covered Securities may be made under such plan during the Lock-Up Period.

 

(c)           As
used in this Agreement, the term “Permitted Transferee” means: (A) the Holder’s immediate family (which shall
mean, with respect to any natural person, any of the following: such person’s spouse or domestic partner, the siblings of such
person and his or her spouse or domestic partner, and the direct descendants and ascendants (including adopted and step children and
parents) of such person and his or her spouses or domestic partners and siblings), (B) any entities controlled by, controlling or under
common control with the Holder, (C) any trust for the direct or indirect benefit of the Holder or the immediate family of the Holder,
(D) if the Holder is a trust, the trustor or beneficiary of such trust or to the estate of a beneficiary of such trust, (E) if the Holder
is an entity, any direct or indirect partners, members or equity holders of the Holder, any affiliate (as defined in Rule 405 promulgated
under the Securities Act) or employee of the Holder or any related investment funds or vehicles controlled or managed by such persons
or entities or their respective affiliates (including, for the avoidance of doubt, where the Holder is a partnership, to its general
partner or a successor partnership or fund, or any other funds managed by such partnership), and (F) a nominee or custodian of a person
or entity to whom a disposition or transfer would be permissible under this Agreement. As used in this Agreement, the term “Upstream
Equity Holder” means, with respect to the Holder, its direct or indirect stockholders, partners, members or other equity holders.

 

(d)           The
Holder agrees to execute and deliver such other customary agreements as may be reasonably requested by the Company or the managing underwriter
in an underwritten transaction that are consistent with this Agreement or that are necessary to give further effect thereto. Any such
agreement entered into after the date hereof (i) shall not be more restrictive than this Agreement and (ii) shall include provisions
providing for the pro rata release of the Holder’s shares that are consistent with Section 1(h) hereof, unless the Holder
agrees otherwise in writing.

 

 

		8	To be included for the MAAC Sponsor.

 

    5

     

    

 

(e)           If
any Sale Transaction is made or attempted contrary to the provisions of this Agreement, such purported Sale Transaction shall be null
and void ab initio, and the Company shall refuse to recognize any such purported transferee of the applicable Covered Securities
as one of its equity holders for any purpose.

 

(f)            During
the Lock-Up Period, each certificate (if any) or book entry evidencing any Covered Securities owned by the Holder shall be stamped or
otherwise imprinted or legended with a legend in substantially the following form, in addition to any other applicable legends:9

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [●], 2021, BY AND AMONG
ROIVANT SCIENCES LTD. (THE “ISSUER”) AND THE ISSUER’S SECURITY HOLDER NAMED THEREIN, AS IT MAY BE AMENDED FROM TIME
TO TIME. A COPY OF SUCH LOCK-UP AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.”

 

(g)           For the avoidance of any doubt, the Holder shall retain all of its rights as a shareholder of the Company during the Lock-Up Period,
including the right to vote any Covered Securities.

 

(h)           Any
discretionary waiver or any amendment, modification or termination of (i) the restrictions set forth in Section 1(a) of any lock-up
agreement entered into on the date hereof by the Company and a holder of its securities and (ii) the lock-up, holdback or similar provisions,
agreements or restrictions set forth in the Company’s bye-laws, the Registration Rights Agreement or any other agreement entered
into on the date hereof between the Company and a holder of its securities, in each case, shall waive, amend, modify or terminate the
provisions of Section 1(a) of this Agreement with respect to the Holder to the same extent and/or in the same aggregate amount, applied
pro rata, to release Covered Securities that are subject to the restrictions set forth in clauses (A), (B) or (C) of Section 1(a)
of this Agreement, respectively, based on the number of shares held by the Holder that are subject to such restrictions[, but taking
into account differences in the restrictions set forth in clause (B) of Section 1(a) of this Agreement with respect to the MAAC Sponsor].10
The Company shall use commercially reasonable efforts to, at least two (2) business days prior to the effective date of
any waiver or release pursuant to this Section 1(h), provide written notice to the Holder stating the number of Covered Securities to
be released.

 

 

		9	To be confirmed with transfer agent that it can implement these
restrictions as a matter of Bermuda law.

 

		10	To be included for the MAAC Sponsor.

 

    6

     

    

 

(i)            In the event the Holder effects a Transfer (as defined in the Transaction Support Agreement entered into by and among the Holder,
the Company and MAAC on the date hereof (as applicable, a “Support Agreement”)) of any Company Pre-Closing Common
Shares, MAAC Warrants and/or Company Equity Awards, as applicable, in accordance with the terms and conditions of the Support Agreement,
the Holder shall cause the transferee of any such Transfer to enter into a written agreement in form and substance reasonably satisfactory
to the Company agreeing to be bound by this Agreement (which will include, for the avoidance of doubt, all of the covenants, agreements
and obligations of the Holder hereunder) prior and as a condition to the occurrence of such Transfer.

 

2.             Termination.
This Agreement shall be binding upon the Holder upon the Holder’s execution and delivery of this Agreement, but this Agreement
shall only become effective upon the Closing. This Agreement shall automatically terminate, without any notice or other action by any
Party, and be void ab initio upon the termination of the Business Combination Agreement in accordance with its terms. This Agreement
shall automatically terminate, without any notice or other action by any Party, upon the expiration of all applicable Lock-Up Periods
applicable to the Holder; provided that such termination shall not release the Holder from any liability for any breach of this
Agreement prior to such termination.

 

3.             Notices.
All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed
to have been duly given) by delivery in person, by e-mail (having obtained electronic delivery confirmation thereof (i.e., an electronic
record of the sender that the email was sent to the intended recipient thereof without an “error” or similar message that
such email was not received by such intended recipient)), or by registered or certified mail (postage prepaid, return receipt requested)
(upon receipt thereof) to the other Parties as follows:

 

If to the Company, to:

 

Roivant Sciences Ltd.

Suite 1, 3rd Floor,

11-12 St. James’s Square,

London SW1Y 4LB,

United Kingdom
 

	 	Attention:	Matthew Gline
		E-mail:	matthew.gline@roivant.com

legalnotices@roivant.com

 

with a copy (which shall not constitute notice)
to:

 

Roivant Sciences, Inc.

151 West 42nd Street, 15th Floor

New York, NY 10036

		Attention:	General Counsel

		E-mail:	jo.chen@roivant.com

 

-and-

 

    7

     

    

 

Davis Polk & Wardwell LLP

450 Lexington Avenue

New York, NY 10017

		Attention:	Derek Dostal; Lee Hochbaum; Brian Wolfe

		Email:	derek.dostal@davispolk.com; lee.hochbaum@davispolk.com; brian.wolfe@davispolk.com

 

If to the Holder, to the address on the Holder’s
signature page hereto;

 

or to such other address as the Party to whom notice is given may have
previously furnished to the others in writing in the manner set forth above.

 

4.             Entire
Agreement. This Agreement [constitutes] [and the Sponsor Support Agreement constitute]11
the entire agreement of the Parties with respect to the subject matter hereof, and supersede[s] all prior agreements and
undertakings, both written and oral, among the Parties with respect to the subject matter of this Agreement, except as otherwise expressly
provided in this Agreement.

 

5.             Amendments and Waivers; Assignment.

 

(a)           Any
provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed by the Holder
and the Company.

 

(b)           Notwithstanding the foregoing, no failure or delay by any Party in exercising any right hereunder shall operate as a waiver thereof
nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.

 

(c)           Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assignable by the Holder without the
Company’s prior written consent (to be withheld or given in its sole discretion). Any attempted assignment of this Agreement not
in accordance with the terms of this Section 5 shall be null and void ab initio.

 

6.             No
Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties and their respective successors and permitted
assigns and is not intended, nor shall be construed, to give any Person, other than the Parties and their respective successors and permitted
assigns, any legal or equitable right, benefit or remedy of any nature whatsoever by reason this Agreement. Nothing in this Agreement,
expressed or implied, is intended to, or shall be deemed to, create a joint venture.

 

7.             Miscellaneous.
Sections 8.5 (Governing Law), 8.7 (Construction; Interpretation), 8.10 (Severability), 8.11 (Counterparts;
Electronic Signatures), 8.15 (Waiver of Jury Trial), 8.16 (Submission to Jurisdiction) and 8.17 (Remedies) of the
Business Combination Agreement are incorporated herein by reference and shall apply to this Agreement, mutatis mutandis.

 

[Signature page follows]

 

 

	11	To be included for the MAAC Sponsor.

 

    8

     

    

 

IN WITNESS WHEREOF, the Parties
have executed and delivered this Lock-Up Agreement as of the date first above written.

 

	 	ROIVANT SCIENCES LTD.
	 	 
	 	By: 	            
	 	Name:
	 	Title:

 

[Signature Page to Lock-Up
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, the Parties
have executed and delivered this Lock-Up Agreement as of the date first above written.

 

	 	[HOLDER]
	 	 
	 	 
	 	By: 	            
	 	Name:
	 	Title:

 

[Signature Page to Lock-Up
Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]